Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis*; D000917:Antibody Formation; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D009698:Nucleoproteins; D011342:Procainamide / Q000009:adverse effects*; D005719:gamma-Globulins / Q000032:analysis*
D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D009698:Nucleoproteins; D005719:gamma-Globulins; D011342:Procainamide